Compound Profile: Kamini Oral Jelly Flavoured
Kamini Oral Jelly Flavoured 100mg is a sildenafil citrate preparation manufactured by Samok Overseas for advanced laboratory investigations into erectile dysfunction mechanisms. This jelly-based formulation provides researchers with an alternative delivery method for studying phosphodiesterase-5 (PDE5) inhibition pathways in controlled experimental settings. The flavoured formulation allows for enhanced palatability studies when investigating oral bioavailability models. Researchers examining vascular physiology and smooth muscle function utilise this compound to evaluate nitric oxide-dependent signalling cascades in tissue culture and organ bath preparations.
Scientific Applications
Laboratory studies investigate sildenafil citrate’s selective PDE5 inhibition properties, which modulate cyclic guanosine monophosphate (cGMP) degradation in vascular smooth muscle cells. Research applications include examining endothelial function in arterial tissue samples, evaluating blood flow dynamics in perfusion models, and analysing nitric oxide synthase pathway interactions. The oral jelly formulation enables researchers at Stroid UK Shop to study dissolution kinetics and absorption profiles compared to conventional tablet preparations. Scientists investigating sildenafil citrate compounds utilise this preparation alongside other selective androgen receptor modulators and research peptides for comprehensive endocrine and cardiovascular studies.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Concentration | 100mg per unit |
| Formulation | Flavoured Oral Jelly |
| Manufacturer | Samok Overseas |
| SKU | EU16434 |
| Storage | Room temperature, dry conditions |
| Research Use | In-vitro laboratory studies only |
Compliance Statement
This product is manufactured exclusively for in-vitro research applications and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and institutional oversight when conducting studies with this compound.
